Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. - Wikidata - wikimedia - TriplyDB

Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis.

Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis.

http://www.wikidata.org/entity/Q52176215

about

Role of CD1d-restricted NKT cells in microbial immunity The role of NKT cells in tumor immunity Peripheral blood but not synovial fluid natural killer T cells are biased towards a Th1-like phenotype in rheumatoid arthritis Role of NK, NKT cells and macrophages in liver transplantation The immunoregulatory role of type I and type II NKT cells in cancer and other diseases Antigen recognition by human gamma delta T cells: pattern recognition by the adaptive immune system Immune privilege: keeping an eye on natural killer T cells.Raising the roof: the preferential pharmacological stimulation of Th1 and th2 responses mediated by NKT cells.Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection.Lymphocytes in cancer development: polarization towards pro-tumor immunity Invariant Valpha14 chain NKT cells promote Plasmodium berghei circumsporozoite protein-specific gamma interferon- and tumor necrosis factor alpha-producing CD8+ T cells in the liver after poxvirus vaccination of mice.Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells The stimulating adventure of KRN 7000.CD1-restricted T-cell responses and microbial infection.Glycolipid antigen induces long-term natural killer T cell anergy in mice.During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein Activation of NKT cells protects mice from tuberculosis.NKT cells in sepsis.NKT cell stimulation with glycolipid antigen in vivo: costimulation-dependent expansion, Bim-dependent contraction, and hyporesponsiveness to further antigenic challenge.Do CD1-restricted T cells contribute to antibody-mediated immunity against Mycobacterium tuberculosis?Activation of natural killer (NK) T cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cells Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells.Mouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity.Decline in number of elevated blood CD3(+) CD56(+) NKT cells in response to intravenous immunoglobulin treatment correlates with successful pregnancy.Activation of natural killer T cells by alpha-galactosylceramide impairs DNA vaccine-induced protective immunity against Trypanosoma cruzi.Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography NKT cells: potential targets for autoimmune disease therapy?Gamma interferon production by hepatic NK T cells during Escherichia coli infection is resistant to the inhibitory effects of oxidative stress.Anterior chamber associated immune deviation (ACAID): regulation, biological relevance, and implications for therapy.NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus.The CD1 family and T cell recognition of lipid antigens.Innate self recognition by an invariant, rearranged T-cell receptor and its immune consequences.Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion.Synthesis and Biological Activities of 5-Thio-α-GalCers.Quantitative microarray analysis of intact glycolipid-CD1d interaction and correlation with cell-based cytokine production Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.Natural killer T cells as targets for immunotherapy of autoimmune diseases.NKT cells and viral immunity.Differential contribution of dendritic cell CD1d to NKT cell-enhanced humoral immunity and CD8+ T cell activation.

P2860

Q24294851-231D195E-2BAA-47B3-8E8E-2D9732F2DAFD Q24648939-9CAC3577-D505-487E-9FDC-7DE02B10FCA9 Q24816601-635F668F-EE7B-4056-984B-70DDD4CFF8CF Q26741191-24DBA65D-F85C-40A6-B286-44CD12954AA9 Q27027556-BFCC8FF6-4A21-4737-9CC5-142149FB98E4 Q28140355-FBABDB5D-F5D3-4A5C-9013-01E7E9ADC827 Q30050558-CED10060-65CA-4EA9-91B3-11D94DCC74B2 Q30408873-707AC87D-2268-4EE0-BA27-6895E0CEFFAF Q33558006-19E6FB9C-420E-4107-8CB8-2229C0AF6C30 Q33712435-C78D8296-9142-4650-8105-2F17FB64EBBE Q33792633-38AC8D16-4408-48F3-B3C3-133E2A6E00F0 Q33818603-2B181DED-2BEB-4241-9505-92A273270A5B Q33843406-2347D35F-4F32-4966-A3D9-956FA26CA7E1 Q33915639-775C494E-BAF3-46B4-889E-CA128972C513 Q33930869-C195AED9-8533-4EB9-9F5E-8E7579A7F25E Q34115997-7AB21BA1-1A1D-4603-A927-CEC1B25B1AAC Q34182581-8F5F361C-D2FA-434D-B302-476BDB1A0C89 Q34189487-D068B719-3EB1-4B27-A403-AB6FFEFB1F0E Q34333607-C5B9EE51-3483-4CA2-AB3D-48E7D5034E29 Q34334259-CFA6A6CE-FC74-4790-ABBF-5AD6030E92A3 Q34467874-033434BA-A483-42F0-86C8-8143143BAF36 Q34479554-DBB6C6AA-1C59-4B8C-9C7A-A59162112DAE Q34519826-B939CC19-8194-4AC7-A600-B027E0DAC271 Q34583580-3644261A-07C4-49B7-AD54-2CD9489AC693 Q34714252-E6776D8A-D41B-468B-B296-E44B435BA3BA Q34722878-2A4A275D-4EB4-4615-8D0C-7A9122A4893C Q34764715-8FF5858A-8BA2-45BF-9C91-5BD0CF1D86F9 Q34931790-379E50D2-2CA1-4527-8DCD-DD355684DB61 Q34993205-9DF80758-6CF2-4129-8565-CA404842376E Q34999264-D077B692-9EE1-4B53-AB3B-8D574A89B825 Q35030902-6036D89E-D15F-42DC-9B82-6D1440B6A900 Q35131643-4379ABEF-5C4D-43F1-9A61-BCFEC54EC0D4 Q35168204-774EF9CB-5EC9-4DA0-80D2-33B01E26F660 Q35171011-3C985333-B56C-4C05-9765-8BDD686B6A58 Q35559790-0C2A5AE7-74AF-430F-B09B-C527A7B367AC Q35684305-86C7DD1D-A0F4-4524-91ED-C0C3975D7EC5 Q35783980-0D2F508A-9F92-4D75-9614-E40F21692E97 Q35798168-D474AB14-3D32-4071-B80C-9701511DB1D6 Q35798179-A8110C26-F6DC-4A7C-9D3A-6F66B9371831 Q35912977-F84EF3BE-75A8-4A89-8D34-030BEE6F3709

P2860

Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis.

http://www.wikidata.org/entity/Q52176215

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

1999年學術文章

@zh-hant

name

Immunization with alpha-galact ...... owards Th2 cytokine synthesis.

@en

Immunization with alpha-galact ...... owards Th2 cytokine synthesis.

@nl

type

label

Immunization with alpha-galact ...... owards Th2 cytokine synthesis.

@en

Immunization with alpha-galact ...... owards Th2 cytokine synthesis.

@nl

prefLabel

Immunization with alpha-galact ...... owards Th2 cytokine synthesis.

@en

Immunization with alpha-galact ...... owards Th2 cytokine synthesis.

@nl

P1433

Q52176215-208B487A-E5E8-4C0D-AEFC-664AAE73611B

P1476

Q52176215-77D9327C-D026-4208-9A81-828548B0FEFB

P2093

Q52176215-6E9D3E97-D74E-4C0B-B0A9-DB07E4FEDF92

Q52176215-E15C7976-CB97-4BF9-97EA-C70CB95FF2CC

P2860

Q52176215-22BF5502-E042-4FD9-BEE7-5D6D44562059

Q52176215-2EF905E0-C509-4FD9-8AB2-AE110D141728

Q52176215-31F1C18F-97A9-4C2B-970B-651D1184460B

Q52176215-3A16532B-BDB2-49FD-B611-596EDDCA0783

Q52176215-3D7F62BE-0F3B-4029-8C56-EA3A29E97216

Q52176215-4227A321-5470-4111-9D9F-89EC9A804FC7

Q52176215-4497317D-C77F-4BB8-B62B-08EDE42681B6

Q52176215-4FCFEC3E-35F8-4F4E-B0E9-333B1667459E

Q52176215-50D4287E-E735-43EC-9510-9FA9C92D25A1

Q52176215-52184C0B-FB64-4771-8FB6-8AF1E33C3EE0

P304

Q52176215-729EE668-B4D9-413A-9C42-657E7F112799

P31

Q52176215-73E736B3-7B1A-4959-94E3-B9F435DF3F79

P356

Q52176215-09EA2A77-3D2C-4A5F-836E-94332C353004

P407

Q52176215-DA4A2808-8F72-4E72-97CD-3688D68AFAC8

P433

Q52176215-79AF60A8-101B-4675-ABF1-7EA124020D6A

P478

Q52176215-DF4C1D63-710A-4084-B443-1425042BD5D6

P50

Q52176215-4A01EFE0-0607-4F0C-AB11-07B7189CAC19

P577

Q52176215-71E5014D-75BB-4147-B8C4-2A5BACFEA0B0

P698

Q52176215-E41A83E0-1429-48AF-BA60-A40BCACDB8B9

P921

Q52176215-9BBB121B-3A44-488E-B60A-FBC24CC9DA98

P356

(SICI)1521-4141(199906)29:06%3C2014::AID-IMMU2014%3E3.0.CO;2-G

P1433

European Journal of Immunology

P1476

Immunization with alpha-galact ...... owards Th2 cytokine synthesis.

@en

P2093

M Kronenberg

http://www.w3.org/2001/XMLSchema#string

N Burdin

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4

CD1-restricted T cell recognition of microbial lipoglycan antigens

Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol.

CD1-mediated immune responses to glycolipids.

Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells.

Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice.

CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3.

Beta 2-microglobulin-dependent T cells are dispensable for allergen-induced T helper 2 responses.

P304

2014-2025

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/(SICI)1521-4141(199906)29:06<2014::AID-IMMU2014>3.0.CO;2-G

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Laurent Brossay

P577

1999-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10382765

http://www.w3.org/2001/XMLSchema#string

P921